VACCINE

Funds management

In the last Investment Centre newsletter for 2021, Money Management looks back at events that shaped markets this year. ...

image
Financial planning

Synchron advisers and staff can receive a $100 Bunnings gift voucher if they get the COVID-19 vaccine. ...

image
Funds management

Drugs are unlikely to be developed as fast as the COVID-19 vaccine, according to American Century fund manager Michael Li, with testing likely to revert back to strict pr...

image
Life/Risk

Despite rumours suggesting otherwise, the Financial Services Council says receiving the COVID-19 vaccine will not invalidate life insurance policies....

image
Financial planning

The delay to the COVID-19 vaccine roll-out could cost the Government more than $4 billion and increase the likelihood of lockdowns and restrictions....

image
Funds management

South East Asian countries that rely on tourism and are experiencing delays in receiving and distributing the COVID-19 vaccine will see a prolonged dip in their markets...

image
Superannuation

The rollout of the COVID-19 vaccine in Australia has allowed superannuation funds to continue to enjoy the continued market recovery, according to SuperRatings....

image
Funds management

COVID-19 may mutate in a way that reduces the effectiveness of current vaccines and this could set back the market’s recovery, according to Magellan. ...

image
Funds management

T. Rowe Price believes the speed of Australia’s economic recovery is being underestimated and is less dependent on the success of a vaccine....

image
Funds management

There is a very high likelihood of a cyclical recovery and further spread tightening in corporate credit due to stronger global GDP growth, Brandywine Global believes....

image
Funds management

In the current volatile environment, failures can lead to permanent losses and dodging losers may be more important than backing winners....

image
Funds management

There has been an ‘atypical’ rotation of stocks since the announcement of the COVID-19 vaccine trials with companies with the lowest levels of profitability outperforming...

image
Financial planning

Stocks that were doing well during the pandemic are unlikely to reverse when a vaccine has been developed as consumers have adjusted to a ‘new normal’....

image
Funds management

Platinum International Health Care manager Bianca Ogden is well placed to benefit from the COVID-19 vaccine trials as her fund holds both of the leading players. ...

image
Funds management

As Moderna becomes the second firm to announce a successful COVID-19 vaccine trial, its shares have risen by more than 400% since the start of the year. ...

image
sub-bgsidebar subscription

Never miss the latest news and developments in wealth management industry

MARKET INSIGHTS

Completely agree Peter. The definition of 'significant change is circumstances relevant to the scope of the advice' is s...

4 weeks 1 day ago

This verdict highlights something deeply wrong and rotten at the heart of the FSCP. We are witnessing a heavy-handed, op...

1 month ago

Interesting. Would be good to know the details of the StrategyOne deal....

1 month 1 week ago

Insignia Financial has confirmed it is considering a preliminary non-binding proposal received from a US private equity giant to acquire the firm. ...

1 week 6 days ago

Six of the seven listed financial advice licensees have reported positive share price growth in 2024, with AMP and Insignia successfully reversing earlier losses. ...

1 week 2 days ago

Specialist wealth platform provider Mason Stevens has become the latest target of an acquisition as it enters a binding agreement with a leading Sydney-based private equi...

1 week 1 day ago